Utah Medical Products, Inc. (NASDAQ:UTMD) Plans $0.31 Quarterly Dividend

Posted by Stanley Muller on Aug 5th, 2026

Utah Medical Products, Inc. (NASDAQ:UTMD – Get Free Report) announced a quarterly dividend on Tuesday, August 4th. Stockholders of record on Thursday, September 17th will be given a dividend of 0.31 per share by the medical instruments supplier on Monday, October 5th. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Thursday, September 17th.

Utah Medical Products has increased its dividend payment by an average of 0.0%per year over the last three years and has increased its dividend every year for the last 3 years.

Utah Medical Products Trading Down 0.6%

NASDAQ UTMD opened at $72.30 on Wednesday. The company’s fifty day simple moving average is $68.77 and its 200-day simple moving average is $66.02. Utah Medical Products has a 52 week low of $53.66 and a 52 week high of $75.75. The stock has a market cap of $229.91 million, a P/E ratio of 22.04 and a beta of 0.35.

Utah Medical Products (NASDAQ:UTMD – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share for the quarter. The business had revenue of $8.53 million during the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Hedge Funds Weigh In On Utah Medical Products

Several institutional investors and hedge funds have recently made changes to their positions in the business. Comerica Bank grew its position in shares of Utah Medical Products by 435.6% during the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock worth $34,000 after buying an additional 440 shares in the last quarter. Fifth Third Bancorp acquired a new stake in Utah Medical Products in the first quarter valued at $43,000. BNP Paribas Financial Markets raised its holdings in Utah Medical Products by 89.6% in the third quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock valued at $67,000 after acquiring an additional 501 shares in the last quarter. State of Wyoming bought a new position in Utah Medical Products during the 2nd quarter valued at $132,000. Finally, Advisory Services Network LLC bought a new position in Utah Medical Products during the 3rd quarter valued at $159,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

About Utah Medical Products

(Get Free Report)

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).